Serial gadolinium‐enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration
Alan J. Thompson(NIHR Queen Square Dementia Biomedical Research Unit), D. H. Miller(NIHR Queen Square Dementia Biomedical Research Unit), B Youl(NIHR Queen Square Dementia Biomedical Research Unit), David MacManus(NIHR Queen Square Dementia Biomedical Research Unit), S G Moore(NIHR Queen Square Dementia Biomedical Research Unit), D. P. E. Kingsley(NIHR Queen Square Dementia Biomedical Research Unit), B. E. Kendall(NIHR Queen Square Dementia Biomedical Research Unit), Anthony Feinstein(NIHR Queen Square Dementia Biomedical Research Unit), W. I. McDonald(NIHR Queen Square Dementia Biomedical Research Unit)
Cited by 220
Abstract
In the planning of MRI protocols to monitor disease activity in multiple sclerosis (MS), the clinical subtype needs to be considered. In this serial gadolinium-enhanced MRI study, we demonstrated differences between patients with early relapsing/remitting MS and benign MS in both the production of new lesions and the occurrence of enhancement.
Related Papers
No related papers found
Powered by citation graph analysis